Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

M69 pCMV pGL3 Luciferase Citations (2)

Originally described in: Other Plasmids
Unpublished

Articles Citing M69 pCMV pGL3 Luciferase

Articles
Nanoparticles Based on Poly (beta-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy. Zhu D, Shen H, Tan S, Hu Z, Wang L, Yu L, Tian X, Ding W, Ren C, Gao C, Cheng J, Deng M, Liu R, Hu J, Xi L, Wu P, Zhang Z, Ma D, Wang H. Mol Ther. 2018 Oct 3;26(10):2443-2455. doi: 10.1016/j.ymthe.2018.07.019. Epub 2018 Jul 25. PubMed
The Tumor Suppressor, p53, Negatively Regulates Non-Canonical NF-kappaB Signaling through miRNAInduced Silencing of NF-kappaB-Inducing Kinase. Jang H, Park S, Kim J, Kim JH, Kim SY, Cho S, Park SG, Park BC, Kim S, Kim JH. Mol Cells. 2020 Jan 31;43(1):23-33. doi: 10.14348/molcells.2019.0239. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.